Celldex Therapeutics Inc
NASDAQ:CLDX

Watchlist Manager
Celldex Therapeutics Inc Logo
Celldex Therapeutics Inc
NASDAQ:CLDX
Watchlist
Price: 27.17 USD -1.24%
Market Cap: 1.8B USD

Wall Street
Price Targets

CLDX Price Targets Summary
Celldex Therapeutics Inc

Wall Street analysts forecast CLDX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CLDX is 54.21 USD with a low forecast of 21.21 USD and a high forecast of 94.5 USD.

Lowest
Price Target
21.21 USD
22% Downside
Average
Price Target
54.21 USD
100% Upside
Highest
Price Target
94.5 USD
248% Upside
Celldex Therapeutics Inc Competitors:
Price Targets
TGTX
TG Therapeutics Inc
45% Upside
PGEN
Precigen Inc
128% Upside
NTRA
Natera Inc
3% Upside
COYA
Coya Therapeutics Inc
171% Upside
SOBI
Swedish Orphan Biovitrum AB (publ)
11% Upside
688331
RemeGen Co Ltd
15% Upside
DVYSR
Devyser Diagnostics AB
41% Upside
2157
Lepu Biopharma Co Ltd
94% Upside

Revenue
Forecast

Revenue Estimate
Celldex Therapeutics Inc

For the last 13 years the compound annual growth rate for Celldex Therapeutics Inc's revenue is -2%. The projected CAGR for the next 4 years is 119%.

-2%
Past Growth
119%
Estimated Growth
Estimates Accuracy
16%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Celldex Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Celldex Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-88%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CLDX's stock price target?
Price Target
54.21 USD

According to Wall Street analysts, the average 1-year price target for CLDX is 54.21 USD with a low forecast of 21.21 USD and a high forecast of 94.5 USD.

What is Celldex Therapeutics Inc's Revenue forecast?
Projected CAGR
119%

For the last 13 years the compound annual growth rate for Celldex Therapeutics Inc's revenue is -2%. The projected CAGR for the next 4 years is 119%.

Back to Top